Nearly half of interventional cardiologists may have pre-cataract lesions

This statement is based on eye exams conducted during the last SCAI meeting (Society for Cardiovascular Angiography and Interventions), where 47% of evaluated operators had radiation related lesions in their crystalline. In time, these might turn into cataract.

¿Cómo debemos antiagregar a los pacientes con ACV-AIT? - Interesantes resultados del estudio POINTStudies on astronauts and Chernobyl survivors have shown a clear association between ionizing radiation and crystalline damage, especially the posterior part, which seems to be more radiosensitive.

 

Last year, during the SCAI meeting, eye exams were conducted to assess the incidence of posterior sub-capsular cataracts among attendees.

 

117 participants were evaluated: 99 had occupational ionizing radiation exposure and 18 were chosen as control (researchers not exposed to radiation).

 

Of these 99 participants exposed to radiation, 47% presented relatively minor lesions, which might eventually turn into cataract, in contrast with 17% of lesions found in the control group.

 

The difference persisted after multivariable adjustment for age, smoking and diabetes.

 

Even though these lesions do not impair vision, they have the potential to evolve into cataract, which is why it is important to detect them as a way to encourage radio protection in the cath lab.

 

This study carried out at SCAI meeting is not new at all since, during 2011 SOLACI annual meeting (Latin American Society of Interventional Cardiology), in the context of the RELID study, researchers had arrived to similar conclusions.

 

The valuable information collected by the RELID study has awarded researchers the “Editors award of JVIR as the Outstanding Clinical Research Paper for 2013”, which SOLACI and specialized radio protection physicians in Latin America, among others Dr. Ariel Durán, take pride in.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...